MedPath

Measuring the increase in exhaled carbon dioxide in spontaneously breathing infants at birth, the RISE study

Not Applicable
Completed
Conditions
eonatal resuscitation
Lung aeration at birth
Neonatal resuscitation
Reproductive Health and Childbirth - Childbirth and postnatal care
Reproductive Health and Childbirth - Complications of newborn
Respiratory - Normal development and function of the respiratory system
Registration Number
ACTRN12615000174583
Lead Sponsor
Prof Peter Davis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

All inborn infants, term and preterm born at 35 weeks or later gestational age, who are not expected to require respiratory support at birth, are eligible for this study.

Exclusion Criteria

Infants will be excluded from analysis if they have a congenital abnormality or condition that might have an adverse effect on breathing or respiratory drive including: infants born to mothers receiving general anesthesia and congenital diaphragmatic hernia. Infants will also be excluded if their parents refuse to give consent to this study. During the study, if there are any signs of respiratory compromise, the study will be abandoned and ventilatory support given according to the Australian Neonatal Resuscitation guidelines.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome for this study will be measuring the exhaled carbon dioxide levels using the NM3 Respiratory Profile Monitor.[Exhaled carbon dioxide levels will be measured every minute for the first ten minutes of life, than once at 1-2 hours of life and once at 12-72 hours of life. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath